Atara Biotherapeutics, Inc. (ATRA) Net income 2016–2025
Atara Biotherapeutics, Inc. (ATRA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$32.7MFY2025 · since FY2016: -$79.0M → $32.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $32.7M | +138.3% |
| FY2024 | -$85.4M | +69.1% |
| FY2023 | -$276.1M | -20.9% |
| FY2022 | -$228.3M | +32.9% |
| FY2021 | -$340.1M | -10.9% |
| FY2020 | -$306.6M | -5.4% |
| FY2019 | -$291.0M | -26.1% |
| FY2018 | -$230.7M | -93.1% |
| FY2017 | -$119.5M | -51.2% |
| FY2016 | -$79.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice